Lisha Huang

Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands.

Medisun Holdings Ltd. engages in research and development of regenerative medicine. It focuses on investing in research, development and commercialization of regenerative medicine, top-tier hospitals and medical centers. The company was founded in 2014 and is headquartered in Hong Kong.

Oriental Richway Investment Ltd. is an investment holding company, which has an interest in the development of biomedical and regenerative medicine systems and products. The company was founded on May 8, 2015 and is headquartered in Hong Kong.